What is the recommended treatment regimen for chronic gout?

Chronic Gout Treatment

Start allopurinol at a low dose (≤100 mg/day, even lower if CKD stage ≥3) as first-line urate-lowering therapy, titrate upward to achieve target serum urate, and always provide concomitant anti-inflammatory prophylaxis for 3-6 months. 1

First-Line Urate-Lowering Therapy (ULT)

Allopurinol is the strongly recommended first-line agent for all patients with chronic gout, including those with moderate-to-severe chronic kidney disease (CKD stage ≥3). 1 This recommendation is based on its proven efficacy when dosed appropriately (often requiring >300 mg/day up to the FDA-approved maximum of 800 mg/day), excellent tolerability, safety profile, and significantly lower cost compared to alternatives.

Critical Dosing Strategy

• Start low: Begin with ≤100 mg/day in most patients
• Start even lower in CKD: Use ≤50 mg/day in patients with CKD stage ≥3 1
• Titrate upward: Gradually increase dose every 2-4 weeks to achieve target serum urate <6 mg/dL
• Don't fear higher doses: Patients often require >300 mg/day, and doses up to 800 mg/day are safe even in CKD when titrated carefully 1

Common pitfall: The outdated practice of capping allopurinol at 300 mg/day or avoiding dose escalation in CKD leads to treatment failure. Starting low mitigates the risk of allopurinol hypersensitivity syndrome (AHS), but subsequent careful titration is both safe and necessary to achieve therapeutic targets. 1

Alternative ULT Options

• Febuxostat: Second-line option; start at ≤40 mg/day and titrate upward 1
• Probenecid: Can be used in patients with normal renal function; start at 500 mg once or twice daily with dose titration 1
• For CKD stage ≥3: Strongly prefer xanthine oxidase inhibitors (allopurinol or febuxostat) over probenecid 1
• Pegloticase: Strongly recommended AGAINST as first-line therapy due to cost, safety concerns, and the need to exhaust oral options first 1

Mandatory Anti-Inflammatory Prophylaxis

You must initiate concomitant anti-inflammatory prophylaxis when starting or intensifying ULT. 1 This is a strong recommendation with moderate-quality evidence from multiple RCTs.

Prophylaxis Regimen

• Options: Colchicine (preferred), NSAIDs, or prednisone/prednisolone based on patient comorbidities
• Duration: Continue for 3-6 months minimum (NOT <3 months) 1
• After stopping: Monitor closely and continue prophylaxis longer if flares persist
• Expect rebound flares: Approximately 30% of patients experience gout flares in the 3 months immediately after stopping prophylaxis, but this returns to baseline levels (12-15%) thereafter 2

Critical caveat: The mean difference in flare rates between the prophylaxis period and the immediate post-prophylaxis period is approximately 15%, so patients must be counseled about this risk and have a clear flare management plan ready. 2

Timing of ULT Initiation

You can start ULT during an acute gout flare rather than waiting for resolution. 1 This is a conditional recommendation, but it offers practical advantages:

• Time efficiency (no need for return visit)
• Patient motivation is highest during symptomatic flare
• Evidence shows no significant extension or worsening of the current flare

Target Serum Urate

While the ACR 2020 guidelines focus on the treat-to-target approach, aim for serum urate <6 mg/dL as the standard target. Some evidence suggests maintaining levels between 180-300 μmol/L (approximately 3-5 mg/dL) for chronic tophaceous gout. 3

Special Populations

Chronic Kidney Disease

• Start allopurinol at lower doses (≤50 mg/day)
• Do not avoid dose escalation - patients with CKD can safely reach doses >300 mg/day with careful titration 1
• Larger body size and diuretic use indicate need for higher allopurinol doses
• Avoid probenecid in CKD stage ≥3

Asymptomatic Hyperuricemia

Do not treat asymptomatic hyperuricemia with ULT, even in patients with comorbid CKD, cardiovascular disease, urolithiasis, or hypertension. 1 The benefits do not outweigh the risks and costs for the majority who will never develop gout.

Treatment Algorithm Summary

1. Confirm diagnosis of chronic gout requiring ULT
2. Start allopurinol at ≤100 mg/day (lower if CKD)
3. Simultaneously start anti-inflammatory prophylaxis (colchicine, NSAID, or corticosteroid)
4. Titrate allopurinol every 2-4 weeks to achieve serum urate <6 mg/dL
5. Continue prophylaxis for 3-6 months minimum
6. Monitor for flares after stopping prophylaxis and have treatment plan ready
7. If allopurinol fails at maximum tolerated dose, switch to febuxostat or add probenecid (if normal renal function)